These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 32273047)

  • 1. Valproic Acid for the Management of Agitation and Delirium in the Intensive Care Setting: A Retrospective Analysis.
    Crowley KE; Urben L; Hacobian G; Geiger KL
    Clin Ther; 2020 Apr; 42(4):e65-e73. PubMed ID: 32273047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing Practices of Valproic Acid for Agitation and Delirium in the Intensive Care Unit.
    Quinn NJ; Hohlfelder B; Wanek MR; Duggal A; Torbic H
    Ann Pharmacother; 2021 Mar; 55(3):311-317. PubMed ID: 32748626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate for agitation in critically ill patients: A retrospective study.
    Gagnon DJ; Fontaine GV; Smith KE; Riker RR; Miller RR; Lerwick PA; Lucas FL; Dziodzio JT; Sihler KC; Fraser GL
    J Crit Care; 2017 Feb; 37():119-125. PubMed ID: 27693975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Valproic Acid for the Management of Delirium and Agitation in the Intensive Care Unit.
    Swayngim R; Preslaski C; Dawson J
    J Pharm Pract; 2024 Feb; 37(1):118-122. PubMed ID: 36154329
    [No Abstract]   [Full Text] [Related]  

  • 5. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit.
    Anger KE
    Curr Pharm Des; 2013; 19(22):4003-13. PubMed ID: 23228319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain, Agitation, and Delirium Guidelines: Interprofessional Perspectives to Translate the Evidence.
    Jablonski J; Gray J; Miano T; Redline G; Teufel H; Collins T; Pascual-Lopez J; Sylvia M; Martin ND
    Dimens Crit Care Nurs; 2017; 36(3):164-173. PubMed ID: 28375992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial.
    Skrobik Y; Duprey MS; Hill NS; Devlin JW
    Am J Respir Crit Care Med; 2018 May; 197(9):1147-1156. PubMed ID: 29498534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Agents for the Management of Agitation and Agitated Delirium in Critically Ill Patients.
    Yeo QM; Wiley TL; Smith MN; Hammond DA
    Crit Care Nurs Q; 2017; 40(4):344-362. PubMed ID: 28834857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine for the Treatment of Hyperactive Delirium Refractory to Haloperidol in Nonintubated ICU Patients: A Nonrandomized Controlled Trial.
    Carrasco G; Baeza N; Cabré L; Portillo E; Gimeno G; Manzanedo D; Calizaya M
    Crit Care Med; 2016 Jul; 44(7):1295-306. PubMed ID: 26925523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic Acid in the Management of Delirium.
    Cuartas CF; Davis M
    Am J Hosp Palliat Care; 2022 May; 39(5):562-569. PubMed ID: 34409869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tackling agitated delirium--the tip of the iceberg.
    Page VJ
    Crit Care; 2009; 13(3):158. PubMed ID: 19591644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are dexmedetomidine and olanzapine suitable to control delirium in critically ill elderly patients? A retrospective cohort study.
    Liu S; Zhao R; Yang R; Zhao H; Ji C; Duan M; Liu J
    Biomed Pharmacother; 2021 Jul; 139():111617. PubMed ID: 33915500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of dexmedetomidine for the control of agitation in critically ill traumatic brain injury patients: a descriptive study.
    Bilodeau V; Saavedra-Mitjans M; Frenette AJ; Burry L; Albert M; Bernard F; Williamson DR
    J Clin Pharm Ther; 2021 Aug; 46(4):1020-1026. PubMed ID: 33606290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain, agitation, delirium, and neuromuscular blockade: a review of basic pharmacology, assessment, and monitoring.
    Altshuler J; Spoelhof B
    Crit Care Nurs Q; 2013; 36(4):356-69. PubMed ID: 24002426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged Refractory ICU Delirium Successfully Treated With Valproic Acid: Case Report and Literature Review.
    Subedi B; Louzon PR; Masood A; Recksieck S
    J Pharm Pract; 2021 Dec; 34(6):984-987. PubMed ID: 32912027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dexmedetomidine on delirium duration of non-intubated ICU patients (4D trial): study protocol for a randomized trial.
    Louis C; Godet T; Chanques G; Bourguignon N; Morand D; Pereira B; Constantin JM;
    Trials; 2018 Jun; 19(1):307. PubMed ID: 29866205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of dexmedetomidine in a cardiac intensive care unit.
    Vicent L; Devesa C; Sousa-Casasnovas I; Juárez M; Iglesias M; Bruña V; Valero-Masa MJ; Gonzalez-Saldivar H; Fernández-Avilés F; Martínez-Sellés M
    J Clin Anesth; 2018 Feb; 44():102-103. PubMed ID: 29175665
    [No Abstract]   [Full Text] [Related]  

  • 18. 'Palliative sedation'? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit.
    Schildmann E; Pörnbacher S; Kalies H; Bausewein C
    Palliat Med; 2018 Jul; 32(7):1189-1197. PubMed ID: 29557260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methodological approach used to develop the 2013 Pain, Agitation, and Delirium Clinical Practice Guidelines for adult ICU patients.
    Barr J; Kishman CP; Jaeschke R
    Crit Care Med; 2013 Sep; 41(9 Suppl 1):S1-15. PubMed ID: 23989088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Clinical Practice Guidelines for Pain, Agitation, and Delirium.
    Krupp A; Balas MC
    Crit Care Nurs Clin North Am; 2016 Jun; 28(2):241-52. PubMed ID: 27215361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.